In summary, our experimental results show that the human‐specific CHRFAM7A gene can reduce renal fibrosis in mice with obstructive nephropathy by down‐regulating the TGF‐β1/Smad2/3 signalling pathway as well as inhibiting the release of inflammatory factors. The gene discussed is TGFB1; the disease is renal fibrosis.